Hadad et al., 2020 - Google Patents
Engineering of NIR fluorescent PEGylated poly (RGD) proteinoid polymers and nanoparticles for drug delivery applications in chicken embryo and mouse modelsHadad et al., 2020
View HTML- Document ID
- 18433371433704647580
- Author
- Hadad E
- Rudnick-Glick S
- Grinberg I
- Yehuda R
- Margel S
- Publication year
- Publication venue
- RSC advances
External Links
Snippet
Proteinoids are non-toxic biodegradable polymers based on thermal step-growth polymerization of natural or synthetic amino acids. Hollow proteinoid nanoparticles (NPs) may then be formed via a self-assembly process of the proteinoid polymers in an aqueous …
- 239000002105 nanoparticle 0 title abstract description 165
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Huang et al. | Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy | |
| Li et al. | Tumor microenvironment-oriented adaptive nanodrugs based on peptide self-assembly | |
| Zhang et al. | Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation | |
| KR101616771B1 (en) | Method of forming non-immunogenic hydrophobic protein nanoparticles and uses therefor | |
| JP5714016B2 (en) | Switching type fluorescent nanoparticle probe and fluorescent molecular imaging method using the same | |
| KR101228106B1 (en) | Nanocarriers with Enhanced Skin Permeability, Cellular Uptake and Tumor Targeting | |
| Ban et al. | Coacervates: Recent developments as nanostructure delivery platforms for therapeutic biomolecules | |
| Li et al. | Development of a reactive oxygen species (ROS)-responsive nanoplatform for targeted oral cancer therapy | |
| Wu et al. | Insulin-loaded liposomes packaged in alginate hydrogels promote the oral bioavailability of insulin | |
| CN101306196B (en) | Biodegradable nano-particles bonded with hemoglobin and production method thereof | |
| US10300024B2 (en) | Proteinoid compounds, process of preparing same and uses thereof | |
| WO2017180820A1 (en) | Compositions and methods for targeted delivery of therapeutic and/or diagnostic agents | |
| CN114080412B (en) | Protein-encapsulated polymeric micelle | |
| Xie et al. | A photo-inducible protein–inorganic nanoparticle assembly for active targeted tumour theranostics | |
| Hadad et al. | Engineering of NIR fluorescent PEGylated poly (RGD) proteinoid polymers and nanoparticles for drug delivery applications in chicken embryo and mouse models | |
| Mu et al. | Collagen-anchored cascade nanoreactors with prolonged intratumoral retention for combined cancer starvation and chemotherapy | |
| Qu et al. | Stepwise dual pH and redox-responsive cross-linked polypeptide nanoparticles for enhanced cellular uptake and effective cancer therapy | |
| Zhang et al. | Enhanced nanoparticle accumulation by tumor-acidity-activatable release of sildenafil to induce vasodilation | |
| CN109498548A (en) | A kind of protein and photosensitizer transmit pH responsiveness polyaminoacid nanogel and preparation method thereof altogether | |
| Zhang et al. | Self-fluorescent drug delivery vector based on genipin-crosslinked polyethylenimine conjugated globin nanoparticle | |
| Chen et al. | Nanodrugs mediate TAMs-related arginine metabolism interference to boost photodynamic immunotherapy | |
| Wang et al. | Polycation-telodendrimer nanocomplexes for intracellular protein delivery | |
| Inbaraj et al. | A comparative study on inhibition of lung cancer cells by nanoemulsion, nanoliposome, nanogold and their folic acid conjugates prepared with collagen peptides from Taiwan tilapia skin | |
| JP6586103B2 (en) | Molecular assembly containing modified RNA and RNA delivery system using the same | |
| WO2014199982A1 (en) | Composition including polycationic triblock copolymer, polyanionic polymer, and biologically active peptide |